At a glance
ClinicalIndex Comparison RecordN/ACompleted· 387 enrolled
Drug / intervention
erythropoietin +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Oxidative Stress and Inflammation Caused by Intravenous Iron in Crohn's Disease Patients With Iron Deficiency Anemia
In Brief
A clinical study evaluating erythropoietin, enteral nutrition., and 1 other intervention for Crohn's Disease. Completed, enrolled 387 participants across 1 site.
Detailed Summary
Extra iron may not be necessary in the treatment of iron deficiency anemia in Crohn's Disease;Oxidative Stress and Inflammation may be Caused by Intravenous Iron in Crohn's Disease Patients With Iron Deficiency Anemia.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCrohn's Disease
CountriesChina
CollaboratorsMinistry of Health, China
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2012
First PostedApr 2013
Primary CompletionJul 2013
Study CompletionNov 2013
TodayJul 2026
First PostedApr 4, 2013
Enrollment StartNov 1, 2012
Primary CompletionJul 1, 2013
Study CompletionNov 1, 2013
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 13.2 years ago
Interventions
erythropoietindrug
enteral nutrition.drug
injection of irondrug